Corbus Pharmaceutical Holdings, Inc. (CRBP) Accused of Faking Clinical Results for Lenabasum According to the complaint against the company for alleged violations of the Securities and Exchange Act of 1934

Tetraphase Pharmaceuticals, Inc. (TTPH) Accused of Misrepresenting Enrollment for Its Drug Trial According to the complaint against the company’s officers and directors for alleged violations of the Securities Exchange Act

NIO Inc. (NIO) Accused of Inflating Its IPO Price According to the complaint for alleged violations of the Securities and Exchange Act of 1933 based on alleged misrepresentations related to

Fusion Connect, Inc. (FSNN) Overstated Earnings According to the complaint for alleged violations of the Securities Exchange Act of 1934 between May 11, 2018 and April 2, 2019, in May

Beazer Homes USA, Inc. (BZH) Improperly Valued Land Held for Future Developments According to the complaint for alleged violations of the Securities Exchange Act of 1934 between August 1, 2014

Heron Therapeutics, Inc. (HRTX) Accused of Misleading Investors According to the complaint for alleged violations of the Securities Exchange Act of 1934 between October 31, 2018 and April 30, 2019,

Floor & Decor Holdings, Inc. (FND) Accused of Inflating Secondary Offering Price According to the complaint against the company for alleged violations of the Securities Exchange Act of 1934 from

AAC Holdings, Inc. (AAC) Accused of Misleading Investors According to the complaint for alleged violations of the Securities Exchange Act of 1934 between March 8, 2017 and April 15, 2019,